Treatment of Subjects with Non-infectious Eye Inflammation that is Currently Controlled with Systematic Treatment

What we are studying

In this clinical research study, participants will be given an investigational drug to learn more about how the drug works in the human body. The purpose of this study is to find out more about how this drug works, and if it has an effect on your eye condition by limiting the action of IL-1?, one of the proteins in your body that causes inflammation.

Who we are studying

• Men and Women
• Races:
  • White
  • African American
  • Asian
  • American Indian or Alaska Native
  • Native Hawaiian or Pacific Islander
  • Other
• All Ethnicities
• Ages 18+

Eligibility Criteria

• Diagnosed with non-infectious intermediate; posterior; or pan-uveitis that is currently controlled with systemic treatment

What is involved

• Study involvement will last about 66 weeks with 18 study visits

Compensation:

$60 for each study visit

Contact Information

Study Coordinator

Cara Everhart

Email

ceverhar@wakehealth.edu

Phone

336-716-6068